XML 124 R104.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK-BASED COMPENSATION - The 2019 Zyla Plan Narrative (Details)
$ / shares in Units, $ in Millions
12 Months Ended
May 20, 2020
USD ($)
$ / shares
shares
Dec. 31, 2021
shares
Zyla Life Sciences    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Merger exchange ratio 2.5  
Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Vesting period   4 years
The 2019 Zyla Plan | Zyla Life Sciences    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Issued (in shares) 1,300,000  
Issued, average fair market value, per share (in dollars per share) | $ / shares $ 2.48  
Issued, value recognized as merger consideration | $ $ 0.4  
The 2019 Zyla Plan | Stock Options    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of shares authorized under plan (in shares)   1,246,469
Shares available for future issuance (in shares)   0
The 2019 Zyla Plan | Stock Options | Zyla Life Sciences    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Term of awards (may not exceed) 10 years  
Vesting period 3 years  
Vesting percentage 33.00%  
The 2019 Zyla Plan | Restricted stock units    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of units awarded (in shares)   0